Sermorelin

Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), corresponding to the GHRH (1-29) fragment. It is studied in laboratory research for its interaction with GHRH-receptor signaling and the secretagogue regulation of growth hormone release from the pituitary.

In research settings, Sermorelin is studied as a GHRH analog in models of the somatotropic (GH/IGF-1) axis, endocrine signaling, and metabolic regulation. Unlike direct growth hormone, GHRH analogs are studied for their action on endogenous GH-secretory signaling pathways, making Sermorelin a common subject of endocrine and metabolic peptide research.

Key Research Highlights

• Studied as a GHRH analog for endogenous growth-hormone secretagogue signaling
• Investigated for GHRH-receptor interaction and somatotropic-axis research
• Examined in models of metabolic and endocrine regulation
• Studied in research on cellular-repair and tissue-signaling pathways
• A frequent subject of endocrine and metabolic peptide research

Product Specifications

• Form: Lyophilized powder
• Vial Size: 10 mg
• Purity: ≥98% (HPLC tested)
• Storage: Store dry at 2-8°C. After reconstitution, refrigerate and use within 20 days.
• For Research Use Only. Not for human consumption.